Lauerma A I
Department of Dermatology, Helsinki University Central Hospital, Finland.
Contact Dermatitis. 1991 Feb;24(2):123-30. doi: 10.1111/j.1600-0536.1991.tb01664.x.
3 corticosteroids have so far been tried as markers for corticosteroid contact sensitivity: hydrocortisone, tixocortol pivalate and hydrocortisone-17-butyrate. The present study compared these steroids for screening in addition to a standard patch test series. Of 727 patients, 28 (3.9%) reacted to tixocortol pivalate and 10 (1.4%) to hydrocortisone-17-butyrate; hydrocortisone gave an allergic reaction in 2 of 521 (0.4%) patients. Serial dilutions suggested that tixocortol pivalate, not marketed in Finland, caused allergic reactions which could possibly be cross-reactions to hydrocortisone. In contrast to previously published data, frequent cross-reactions occurred with hydrocortisone-17-butyrate and tixocortol pivalate. All allergic reactions to other corticosteroids found by testing with tixocortol pivalate concurred with reactions to hydrocortisone-17-butyrate. The study suggests that the most effective choice for routine testing for corticosteroid contact sensitivity would be both tixocortol pivalate and hydrocortisone-17-butyrate.
目前已尝试将3种皮质类固醇用作皮质类固醇接触性过敏的标志物:氢化可的松、匹伐硫代可的松和丁酸氢化可的松。本研究除了使用标准斑贴试验系列外,还比较了这些类固醇用于筛查的情况。在727例患者中,28例(3.9%)对匹伐硫代可的松有反应,10例(1.4%)对丁酸氢化可的松有反应;521例患者中有2例(0.4%)对氢化可的松出现过敏反应。系列稀释表明,在芬兰未上市的匹伐硫代可的松引起的过敏反应可能是对氢化可的松的交叉反应。与先前发表的数据相反,丁酸氢化可的松和匹伐硫代可的松之间频繁出现交叉反应。通过匹伐硫代可的松检测发现的所有对其他皮质类固醇的过敏反应都与对丁酸氢化可的松的反应一致。该研究表明,皮质类固醇接触性过敏常规检测的最有效选择是匹伐硫代可的松和丁酸氢化可的松。